Evidence map›Paper›PMID 37116937›Full record

ReviewGlobal health, science and practice2023

Addressing the Need for a Preexposure Prophylaxis Monitoring and Evaluation Implementation Guide: Experience From Zambia.

Marie-Claude C Lavoie, Natalie Blanco, Linah K Mwango, Brooke E Nichols, Anna Whittington, Brianna Lindsay, Olufunso Adebayo, Morley Mujansi, Kalima Tembo, Lottie Hachaambwa and 3 more

Abstract readReview
In one paragraph

Review in Global health, science and practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Marie-Claude C LavoieDivision of Global Health Sciences, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA. mlavoie@ihv.umaryland.edu.
Natalie BlancoInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
Linah K MwangoCenter for International Health Education and Biosecurity-Zambia, Lusaka, Zambia.
Brooke E NicholsDepartment of Global Health, School of Public Health, Boston University, Boston, Massachusetts, USA.
Anna WhittingtonInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
Brianna LindsayInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
Olufunso AdebayoMaryland Global Initiatives Corporation Zambia, Lusaka, Zambia.
Morley MujansiMaryland Global Initiatives Corporation Zambia, Lusaka, Zambia.
Kalima TemboMaryland Global Initiatives Corporation Zambia, Lusaka, Zambia.
Lottie HachaambwaInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
Daliso MumbaNational HIV/AIDS/STI/TB Council, Lusaka, Zambia.
Bupe MusondaZambia Ministry of Health, Lusaka, Zambia.
Cassidy W ClaassenDivision of Global Health Sciences, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Funding

Role of Mitochondrial CYP2E1 in Chemical Exposure-Driven NeurodegenerationF32ES027306 · NIEHS · DUKE UNIVERSITY · PI HARTMAN, JESSICA HELENE · 2016 to 2018
$171k
NIEHS NIH HHS 27306C0004
6 · The paper itself

Abstract

backgroundThe HIV care continuum comprises well-defined steps and indicators. In contrast, indicators along the preexposure prophylaxis (PrEP) cascade are still in the early stages of implementation. Monitoring and evaluation (M&E) of PrEP services is critical to optimizing PrEP uptake and adherence during periods of HIV risk. We provide an overview of global indicators for PrEP, describe the development process and outcomes of Zambia's 2022 NATIONAL M&E GUIDE DEVELOPMENT PROCESS: During the scale-up of PrEP, the Zambia Ministry of Health (MOH) and the National HIV/AIDS/STI/TB Council recognized the need for a national unified monitoring system to guide the effective implementation of PrEP services. Stakeholders from the MOH, civil society, professional organizations, funding agencies, and implementing partners developed the

conclusionsUsing a collaborative and consensus-based approach, Zambia developed its first national PrEP M&E implementation guide to provide standardized guidelines for optimizing the delivery, monitoring, and evaluation of PrEP service delivery. Zambia's experience can inform other countries in sub-Saharan Africa as they develop national M&E implementation approaches for PrEP.

Indexed as

Acquired Immunodeficiency SyndromeAnti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisHumansProgram EvaluationZambiaAnti-HIV Agents

Identifiers

PMID37116937
PMCPMC10141438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.